LEADER 01692nam0 2200349 i 450 
001 SUN0125086
005 20191030111207.853
010   $d0.00
017 70$2O$a978-4-431-55573-5
100   $a20191030d2018       |0engc50      ba
101   $aeng
102   $aJP
105   $a||||    |||||
200 1 $a*Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents$fAkihiro Hirakawa ... [et al.]
205   $aTokyo : Springer, 2018
210   $axiii$d89 p. ; 24 cm
215   $aPubblicazione in formato elettronico
410  1$1001SUN0102916$12001 $a*SpringerBriefs in statistics$1210  $aBerlin$cSpringer$d2011-.
410  1$1001SUN0113968$12001 $a*SpringerBriefs in Statistics. JSS research series in statistics$1210  $aBerlin$cSpringer.
606   $a92-XX$xBiology and other natural sciences [MSC 2020]$2MF$3SUNC020839
606   $a62-XX$xStatistics [MSC 2020]$2MF$3SUNC022998
606   $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$2MF$3SUNC024649
606   $a92B15$xGeneral Biostatistics [MSC 2020]$2MF$3SUNC026442
620   $dTokyo$3SUNL000048
702  1$aHirakawa$b, Akihiro$3SUNV096541
712   $aSpringer$3SUNV000178$4650
801   $aIT$bSOL$c20210503$gRICA
856 4 $uhttp://doi.org/10.1007/978-4-431-55573-5
912   $aSUN0125086
950   $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08CONS      e-book                  1260        $e08eMF1260              20191030            
996   $aModern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents$91563840
997   $aUNICAMPANIA